Company Filing History:
2 out of 5,448 
1 out of 1 
1 out of 6 Years Active: 2022-2025
Title: Innovations of Désiree Tampe in Chronic Organ Injury Treatment
Introduction
Désiree Tampe is a notable inventor based in Goettingen, Germany. He has made significant contributions to the field of medical science, particularly in the prevention and treatment of chronic organ injuries. His innovative approaches aim to enhance therapeutic outcomes for patients suffering from progressive organ damage.
Latest Patents
Désiree Tampe holds a patent for the prevention or treatment of chronic organ injury. The patent focuses on novel therapeutic strategies designed to prevent, treat, and delay the progression of chronic injury, loss of functional parenchymal cells, or fibrosis in organs. The disclosed agents aim to increase homodimer-formation of ARNT in the affected organs. Specifically, the patent outlines agents that may include an inhibitor of protein phosphatase 2A (PP2A) activity, an inhibitor of the transcriptional repressor complex FKBP12/YY1, or an expression construct capable of over-expressing ARNT in the organ.
Career Highlights
Throughout his career, Désiree Tampe has worked with several prestigious institutions. He has been associated with Georg-August-Universität Göttingen, Universitätsmedizin Göttingen, and the University of Texas System. His work in these institutions has contributed to advancing research in chronic organ injury and therapeutic interventions.
Collaborations
Désiree Tampe has collaborated with notable colleagues, including Michael Zeisberg and Elisabeth Zeisberg. These collaborations have further enriched his research and innovation in the field.
Conclusion
Désiree Tampe's contributions to the treatment of chronic organ injuries through his innovative patent demonstrate his commitment to advancing medical science. His work continues to inspire future research and development in therapeutic strategies for organ health.